CVA Family Office’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
CVA Family Office's XYL Position: Q2 2026 in Review
CVA Family Office reduced its Xylem (XYL) stake by 43% in Q2 2026, selling an estimated $16.2K and leaving 189 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #788.
CVA Family Office first reported a position in XYL in Q1 2021 and has held it in 19 quarters since. The position peaked at $39.3K in Q1 2026. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- CVA Family Office held 189 shares of Xylem worth $22.3K as of Q2 2026.
- CVA Family Office sold 140 Xylem shares in Q2 2026, an estimated $16.2K.
- Xylem made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #788 holding.
- CVA Family Office first reported a position in Xylem in Q1 2021 and has held it in 19 quarters since.
- CVA Family Office's Xylem position peaked at $39.3K in Q1 2026.
- 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.